184 related articles for article (PubMed ID: 27898621)
1. Review of Targeted Therapies for Periocular Tumors.
Mehta VJ; Ling J; Sobel RK
Int Ophthalmol Clin; 2017; 57(1):153-168. PubMed ID: 27898621
[No Abstract] [Full Text] [Related]
2. Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma.
Yin VT; Pfeiffer ML; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2013; 29(2):87-92. PubMed ID: 23446297
[TBL] [Abstract][Full Text] [Related]
3. Changing pathology with changing drugs: skin cancer.
Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
[TBL] [Abstract][Full Text] [Related]
4. [New chemical preparation plumfain used in the treatment of patients with malignant neoformations of the eyelids and eyeball].
Babenko GA; Tsok RM; Shkromida MI; Terent'eva LS
Oftalmol Zh; 1979; 34(5):297-9. PubMed ID: 503427
[No Abstract] [Full Text] [Related]
5. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
6. Re: "Imiquimod 5% cream for the treatment of periocular basal cell carcinoma".
Pakdel F; Kashkouli MB
Ophthalmic Plast Reconstr Surg; 2011; 27(4):305; author reply 305-6. PubMed ID: 20966793
[No Abstract] [Full Text] [Related]
7. Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.
Demirci H; Worden F; Nelson CC; Elner VM; Kahana A
Ophthalmic Plast Reconstr Surg; 2015; 31(6):463-6. PubMed ID: 25675162
[TBL] [Abstract][Full Text] [Related]
8. Cumulative experience with Solcoderm in the treatment of basal cell epithelioma.
Schewach-Millet M; Azizi E; Semah D
Dermatologica; 1984; 168 Suppl 1():43-5. PubMed ID: 6468720
[TBL] [Abstract][Full Text] [Related]
9. Indications and limitations of vismodegib for basal cell carcinoma.
Yin VT; Sniegowski M; Esmaeli B
JAMA Ophthalmol; 2014 Jul; 132(7):905-6. PubMed ID: 25010179
[No Abstract] [Full Text] [Related]
10. Indications and limitations of vismodegib for basal cell carcinoma--reply.
Gill HS; Moscato EE; Silkiss RZ
JAMA Ophthalmol; 2014 Jul; 132(7):906. PubMed ID: 25010181
[No Abstract] [Full Text] [Related]
11. Skin cancer treatment options: new horizons and promises for the future.
Semkova K; Tchernev G; Wollina U
Wien Med Wochenschr; 2013 Aug; 163(15-16):345-6. PubMed ID: 23846703
[No Abstract] [Full Text] [Related]
12. Urea treatment of skin malignancies.
Danopoulos ED; Danopoulou IE
Lancet; 1974 Jan; 1(7848):115-9. PubMed ID: 4130312
[No Abstract] [Full Text] [Related]
13. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part I.
Walls B; Jordan L; Diaz L; Miller R
J Drugs Dermatol; 2014 Aug; 13(8):947-52. PubMed ID: 25116973
[TBL] [Abstract][Full Text] [Related]
14. Medical management of cutaneous malignancies.
Gibbs P; Gonzalez R; Lee LA; Walsh P
Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042
[No Abstract] [Full Text] [Related]
15. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part II.
Walls B; Jordan L; Diaz L; Miller R
J Drugs Dermatol; 2014 Aug; 13(8):955-8. PubMed ID: 25116974
[TBL] [Abstract][Full Text] [Related]
16. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
[No Abstract] [Full Text] [Related]
17. Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series.
Murphy ME; Brodland DG; Zitelli JA
Dermatol Surg; 2008 Sep; 34(9):1258-63. PubMed ID: 18554288
[No Abstract] [Full Text] [Related]
18. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
19. [Molecular targeted therapy in skin neoplasms].
Uhara H; Okuyama R
Nihon Rinsho; 2012 Nov; 70 Suppl 8():486-91. PubMed ID: 23513888
[No Abstract] [Full Text] [Related]
20. Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.
Carneiro RC; de Macedo EM; Matayoshi S
Ophthalmic Plast Reconstr Surg; 2010; 26(2):100-2. PubMed ID: 20305508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
